Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression

Biochemical Journal

Volumn 391, Issue 3, 2005, Pages 503-511

  Oleinik, Natalia V ^a   Krupenko, Natalia I ^a   Priest, David G ^a   Krupenko, Sergey A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

10 formyltetrahydrofolate dehydrogenase; Apoptosis; Folate; p53; RNA interference (RNAi); Tumour suppressor

Indexed keywords

ACTIVATION ENERGY; CYTOLOGY; ENZYMES; PROTEINS; RNA; TUMORS;

10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE; APOPTOSIS; FOLTE; P53; RNA INTERFERENCE (RNAI); TUMOUR SUPPRESSOR;

CELLS;

FORMATE TETRAHYDROFOLATE LIGASE; PROTEIN; PROTEIN BCL 2; PROTEIN P53; PROTEIN PUMA; SERINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; TUMOR SUPPRESSOR GENE;

ADENOSINE TRIPHOSPHATE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANOSINE TRIPHOSPHATE; HUMANS; LUNG NEOPLASMS; MUTAGENESIS, SITE-DIRECTED; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PHOSPHORYLATION; PROTEIN TRANSPORT; RNA INTERFERENCE; SERINE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 27744560722     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20050533     Document Type: Article

References (59)

1. Vousden, K. H. and Lu, X. (2002) Live or let die: the cell's response to p53. Nat. Rev. Cancer 2, 594-604
2. Pietenpol, J. A. and Stewart, Z. A. (2002) Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 181-182, 475-481
3. Burns, T. F. and El-Deiry, W. S. (1999) The p53 pathway and apoptosis. J. Cell. Physiol. 181, 231-239
4. Pluquet, O. and Hainaut, P. (2001) Genotoxic and non-genotoxic pathways of p53 induction. Cancer Lett. 174, 1-15
5. Lowe, S. W. and Ruley, H. E. (1993) Stabilization of the p53 tumour suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7, 535-545
6. Stewart, Z. A., Tang, L. J. and Pietenpol, J. A. (2001) Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner. Oncogene 20, 113-124
7. Linke, S. P., Clarkin, K. C., Di Leonardo, A., Tsou, A. and Wahl, G. M. (1996) A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10, 934-947
8. Koumenis, C., Alarcon, R., Hammond, E., Sutphin, P., Hoffman, W., Murphy, M., Derr, J., Taya, Y., Lowe, S. W., Kastan, M. and Giaccia, A. (2001) Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol. Cell. Biol. 21, 1297-1310
9. May, P. and May, E. (1999) Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18, 7621-7636
10. Vogelstein, B., Lane, D. and Levine, A. J. (2000) Surfing the p53 network. Nature (London) 408, 307-310
11. Haupt, Y., Maya, R., Kazaz, A. and Oren, M. (1997) Mdm2 promotes the rapid degradation of p53. Nature (London) 387, 296-299
12. Kubbutat, M. H., Jones, S. N. and Vousden, K. H. (1997) Regulation of p53 stability by Mdm2. Nature (London) 387, 299-303
13. Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J. and Livingston, D. M. (1997) Binding and modulation of p53 by p300/CBP coactivators. Nature (London) 387, 823-827
14. Thornborrow, E. C. and Manfredi, J. J. (2001) The tumour suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter. J. Biol. Chem. 276, 15598-15608
15. Li, G. M., Presnell, S. R. and Gu, L. (2003) Folate deficiency, mismatch repair-dependent apoptosis, and human disease. J. Nutr. Biochem. 14, 568-575
16. Wagner, C. (1995) Biochemical role of folate in cellular metabolism. In Folate in Health and Disease (Bailey, L. B., ed.), pp. 23-42, Marcel Dekker, Inc., New York
17. Blount, B. C., Mack, M. M., Wehr, C. M., MacGregor, J. T., Hiatt, R. A., Wang, G., Wickramasinghe, S. N., Everson, R. B. and Ames, B. N. (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. U.S.A. 94, 3290-3295
18. Pogribny, I. P., Pogribna, M., Christman, J. K. and James, S. J. (2000) Single-site methylation within the p53 promoter region reduces gene expression in a reporter gene construct: possible in vivo relevance during tumorigenesis. Cancer Res. 60, 588-594
19. Koury, M. J., Home, D. W., Brown, Z. A., Pietenpol, J. A., Blount, B. C., Ames, B. N., Hard, R. and Koury, S. T. (1997) Apoptosis of late-stage erythroblasts in megaloblastic anemia: association with DNA damage and macrocyte production. Blood 89, 4617-4623
20. Jackson, R. C. (1999) Antifolate drugs: past and future perspectives. In Antifolate Drugs in Cancer Therapy (Jackman, A. L., ed.), pp. 1-12, Humana Press, Totowa, NJ
21. Chu, E. and Allegra, C. J. (1996) Antifolates. In Cancer Chemotherapy and Biotherapy: Principles and Practice (Chabner, B. A. and Longo, D. L., eds.), pp. 109-148, Lippincott-Raven Publishers, Philadelphia
22. Banerjee, D., Mayer-Kuckuk, P., Capiaux, G., Budak-Alpdogan, T., Gorlick, R. and Bertino, J. R. (2002) Novel aspects of resistance to drugs targeted to dihydrofolate reductaseand thymidylate synthase. Biochim. Biophys. Acta 1587, 164-173
23. Lu, X., Errington, J., Curtin, N. J., Lunec, J. and Newell, D. R. (2001) The impact of p53 status on cellular sensitivity to antifolate drugs. Clin. Cancer Res. 7, 2114-2123
24. Zhang, C. C., Boritzki, T. J. and Jackson, R. C. (1998) An inhibitor of glycinamide ribonucleotide formyltransferase is selectively cytotoxic to cells that lack a functional G1 checkpoint. Cancer Chemother. Pharmacol. 41, 223-228
25. Ju, J., Pedersen-Lane, J., Maley, F. and Chu, E. (1999) Regulation of p53 expression by thymidylate synthase. Proc. Natl. Acad. Sci. U.S.A. 96, 3769-3774
26. Liu, J., Schmitz, J. C., Lin, X., Tai, N., Yan, W., Farrell, M., Bailly, M., Chen, T. and Chu, E. (2002) Thymidylate synthase as a translational regulator of cellular gene expression. Biochim. Biophys. Acta 1587, 174-182
27. Oleinik, N. V. and Krupenko, S. A. (2003) Ectopic expression of 10-formyltetrahydrofolate dehydrogenase in a549 cells induces g(1) cell cycle arrest and apoptosis. Mol. Cancer Res. 1, 577-588
28. Kisliuk, R. L. (1999) Folate biochemistry in relation to antifolate selectivity. In Antifolate Drugs in Cancer Therapy (Jackman, A. L., ed.), pp. 13-36, Humana Press, Totowa, NJ
29. Krupenko, S. A. and Oleinik, N. V. (2002) 10-formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down-regulated in tumour tissues and possesses suppressor effects on cancer cells. Cell Growth Differ. 13, 227-236
30. 29a Daxecker, H., Raab, M., Cichna, M., Markl, P. and Muller, M. M. (2001) Determination of the effects of mycophenolic acid on the nucleotide pool of human peripheral blood mononuclear cells in vitro by high-performance liquid chromatography. Clin. Chim. Acta 310, 81-87
31. 29b Pizzorno, G., Moroson, B. A., Cashmore, A. R. and Beardsley, G. P. (1991) (6R)-5,10-Dideaza-5,6,7,8-tetrahydrofolic acid effects on nucleotide metabolism in CCRF-CEM human T-lymphoblast leukemia cells. Cancer Res. 51, 2291-2295
32. 29c Hwang, H. S., Davis, T. W., Houghton, J. A. and Kinsella, T. J. (2000) Radiosensitivity of thymidylate synthase-deficient human tumour cells is affected by progression through the G1 restriction point into S-phase: implications for fluoropyrimidine radiosensitization. Cancer Res. 60, 92-100
33. Szak, S. T. and Pietenpol, J. A. (1999) High affinity insertion/deletion lesion binding by p53. Evidence for a role of the p53 central domain. J. Biol. Chem. 274, 3904-3909
34. Kern, S. E., Pietenpol, J. A., Thiagalingam, S., Seymour, A., Kinzler, K. W. and Vogelstein, B. (1992) Oncogenic forms of p53 inhibit p53-regulated gene expression. Science (Washington, D.C.) 256, 827-830
35. Paddison, P. J., Gaudy, A. A. and Hannon, G. J. (2002) Stable suppression of gene expression by RNAi in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99, 1443-1448
36. Hietanen, S., Lain, S., Krausz, E., Blattner, C. and Lane, D. P. (2000) Activation of p53 in cervical carcinoma cells by small molecules. Proc. Natl. Acad. Sci. U.S.A. 97, 8501-8506
37. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W. and Vogelstein, B. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (Washington, D.C.) 282, 1497-1501
38. Saito, S., Yamaguchi, H., Higashimoto, Y., Chao, C., Xu, Y., Fornace, Jr, A. J., Appella, E. and Anderson, C. W. (2003) Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J. Biol. Chem. 278, 37536-37544
39. Villunger, A., Michalak, E. M., Coultas, L., Mullauer, F., Bock, G., Ausserlechner, M. J., Adams, J. M. and Strasser, A. (2003) p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science (Washington, D.C.) 302, 1036-1038
40. Dotto, G. P. (2000) p21(WAF1/Cip1): more than a break to the cell cycle? Biochim. Biophys. Acta 1471, M43-M56
41. Shapiro, G. I., Koestner, D. A., Matranga, C. B. and Rollins, B. J. (1999) Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines. Clin. Cancer Res. 5, 2925-2938
42. Brummelkamp, T. R., Bernards, R. and Agami, R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science (Washington, D.C.) 296, 550-553
43. Appella, E. and Anderson, C. W. (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268, 2764-2772
44. Oren, M. (2003) Decision making by p53: life, death and cancer. Cell. Death Differ. 10, 431-442
45. Shieh, S. Y., Taya, Y. and Prives, C. (1999) DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J. 18, 1815-1823
46. Haupt, S., Louria-Hayon, I. and Haupt, Y. (2003) P53 licensed to kill? Operating the assassin. J. Cell. Biochem. 88, 76-82
47. Jabbur, J. R., Huang, P. and Zhang, W. (2000) DNA damage-induced phosphorylation of p53 at Ser-20 correlates with p21 and Mdm-2 induction in vivo. Oncogene 19, 6203-6208
48. Hupp, T. R. and Lane, D. P. (1994) Allosteric activation of latent p53 tetramers. Curr. Biol. 4, 865-875
49. Sakaguchi, K., Sakamoto, H., Lewis, M. S., Anderson, C. W., Erickson, J. W., Appella, E. and Xie, D. (1997) Phosphorylation of Ser-392 stabilizes the tetramer formation of tumour suppressor protein p53. Biochemistry 36, 10117-10124
50. Kapoor, M., Hamm, R., Yan, W., Taya, Y. and Lozano, G. (2000) Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation. Oncogene 19, 358-364
51. Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M. and Green, D. R. (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science (Washington, D.C.) 303, 1010-1014
52. Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P. and Moll, U. M. (2003) p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 11, 577-590
53. Yu, J., Wang, Z., Kinzler, K. W., Vogelstein, B. and Zbang, L. (2003) PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100, 1931-1936
54. Jeffery, C. J. (1999) Moonlighting proteins. Trends Biochem. Sci. 24, 8-11
55. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S. and Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell (Cambridge, Mass.) 91, 479-489
56. Daugas, E., Nochy, D., Ravagnan, L., Loeffler, M., Susin, S. A., Zamzami, N. and Kroemer, G. (2000) Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett. 476, 118-123
57. Ishitani, R., Tajima, H., Takata, H., Tsuchiya, K., Kuwae, T., Yamada, M., Takahashi, H., Tatton, N. A. and Katsube, N. (2003) Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs. Prog. Neuro-Psycbopharmacol. Biol. Psychiatry 27, 291-301
58. Chumanevich, A. A., Krupenko, S. A. and Davies, C. (2004) The crystal structure of the hydrolase domain of 10-formyltetrahydrofolate dehydrogenase: mechanism of hydrolysis and its interplay with the dehydrogenase domain. J. Biol. Chem. 279, 14355-14364
59. Chernova, O. B., Chernov, M. V., Agarwal, M. L., Taylor, W. R. and Stark, G. R. (1995) The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited. Trends Biochem. Sci. 20, 431-434